The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index; 19 of the 88 sources its claims cite were checked for support.
Excess Body Weight and Gallstone Disease
Open accessAbstract
Background: Approximately one fifth of adults are diagnosed with gallstones worldwide. Of these, around 25% develop gallstone disease (indicated by the presence of symptoms) and undergo cholecystectomy. Summary: The risk of gallstones is influenced by a combination of genetic and lifestyle factors, such as excess body weight. In fact, body mass has been demonstrated to be a major risk factor for symptomatic gallstones. Rapid weight loss can also initiate a prolithogenic state and further increase the likelihood of either gallstone formation or existing gallstones becoming symptomatic; however, sensible weight loss strategies can mitigate this risk. This review discusses the role of excess body weight and the risk of gallstone disease, as well as the options available for the prevention of symptomatic gallstones. Key Messages: Healthy weight loss diets combined with regular physical activity can promote successful weight loss and weight maintenance and reduce the risk of gallstones. Should rapid weight loss be required for health reasons or be expected, e.g., after bariatric surgery, prophylactic ursodeoxycholic acid during the period of weight reduction has been demonstrated to reduce the incidence of gallstones formation or symptomatic gallstone occurrence. The recent German guidelines on gallstones recommend simultaneous cholecystectomy during bariatric surgery but only for those with preexisting symptomatic stones.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Excess body weight is a major modifiable risk factor for cholesterol gallstones and symptomatic gallstone disease, while rapid weight loss and weight cycling can further increase risk. Sensible weight loss, healthy diet and activity, and prophylactic ursodeoxycholic acid during high-risk weight reduction can reduce gallstone formation and symptoms.
Key findings
- Gallstones affect up to 20% of adults worldwide; about 25% develop symptoms/complications, and approximately 90% of stones are cholesterol stones.
- Increased BMI is causally linked to symptomatic gallstones: in a Mendelian randomization study of 77,679 individuals, symptomatic gallstones occurred in 5.2% (4,106 individuals) over up to 34 years, with findings more distinct in women.
- Rapid weight loss (>1.5 kg/week) and excessive weight reduction (>25% body weight) increase gallstone risk; after gastric bypass or biliopancreatic diversion, biliary sludge/gallstones occurred in 30% during the 6-month period, and a comparable 30% incidence was reported after sleeve gastrectomy at 6–12 months. Weight cycling increased cholecystectomy risk by 31% for moderate (4.5–8.5 kg) and 68% for severe (≥9 kg) fluctuations.
- Prophylactic ursodeoxycholic acid (UDCA) reduced gallstone formation by as much as 58% in randomized controlled trials; a minimum dose of 500 mg/day is recommended. In one randomized trial of 190 patients after one anastomosis gastric bypass, gallstones at 12 months occurred in 4.2% with UDCA 600 mg/day versus 25.2% in controls (p < 0.05), with UDCA the only significant predictor (HR = 0.17; 95% CI 0.06–0.48; p < 0.001). Recent German and European guidelines recommend simultaneous cholecystectomy during bariatric surgery only for patients with preexisting symptomatic gallstones.
Methods
- Narrative review focusing on modifiable risk and prevention of gallstones related to obesity in adults.
- Synthesizes evidence on body weight, fat distribution, pathophysiological mechanisms, rapid weight loss and weight cycling, diet and physical activity, prophylactic UDCA, cholecystectomy, and guideline recommendations.
- Draws on epidemiological studies, randomized controlled trials, meta-analyses, and guidelines, including a Mendelian randomization study, the Swedish Obese Subjects study, and German/European gallstone guidelines.
Limitations
- The paper does not state a limitations section; it reports no funding and no conflicts of interest.
- Evident from the text: this is a narrative review without a described systematic search strategy or formal risk-of-bias assessment.
- Evident from the text: the evidence base includes observational, retrospective, and heterogeneous intervention studies, and some findings come from specific populations or settings, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
19 of 88 cited sources checked · 2 supported · 1 flagged · accuracy not yet measured
- Premisecitation
Increased BMI is causally linked to the risk of symptomatic gallstones.
“an increased BMI has been demonstrated to be causally linked to the risk of symptomatic stones, as illustrated in a mendelian randomization study in 77,679 individuals [8].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [8] source
The Discussion reports a Mendelian randomization study of 77,679 individuals and finds genetically elevated BMI associated with increased risk of symptomatic gallstone disease. It concludes that elevated BMI is likely a causal risk factor, but the citing sentence’s “has been demonstrated” is more definitive than the paper’s qualified conclusion. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Weight cycling is an independent risk factor for gallstones.
“Weight cycling (i.e., weight that is lost and regained) is an independent risk factor for gallstones [34][35][36].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [34] source
- cites [35] source
- cites [36] source
The Introduction (page not provided) says obesity and rapid weight loss increase the risk of gallstone formation. It does not address weight regain or establish that weight cycling is an independent risk factor; searches for weight cycling and weight regain found no such passage. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Higher concentrations of high-sensitivity C-reactive protein (CRP) are an independent risk factor for new-onset cholesterol gallstones.
“a Chinese study observed higher concentrations of (high-sensitivity) C reactive protein (CRP) to be an independent risk factor for new-onset cholesterol gallstones [22].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [22] source
The Introduction describes CRP as an inflammatory marker associated with obesity, and §3.1 identifies high-sensitivity CRP as a marker used to screen for inflammation. Searches for gallstones, new-onset cholesterol gallstones, and a Chinese study found no passage linking CRP to gallstone risk. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
The prevalence of gallstones in individuals younger than 50 years with obesity and metabolic syndrome was identical to the prevalence in elderly people who were metabolically healthy and not obese.
“the prevalence of gallstones in individuals younger than 50 years with obesity and metabolic syndrome was identical to the prevalence of gallstones in elderly people who were metabolically healthy and not obese.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] source
The Conclusions describe the two groups’ gallstone prevalence as equal, supporting the comparison. The Results (Baseline characteristics) give rates of 7.2% and 6.8%, however, so the prevalences were similar rather than numerically identical. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
A high-sensitivity CRP concentration >3 mg/L is associated with a 12% increased risk of stones.
“a high-sensitivity CRP concentration >3 mg/L was associated with a 12% increased risk of stones.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [22] source
The Introduction identifies CRP as an inflammatory marker associated with obesity, but does not discuss stone risk. Searches for high-sensitivity CRP, the >3 mg/L threshold, stones, and a 12% increase found no passage addressing the claimed association; no page number is available in our copy. (LLM, conf=0.77)
Experimental — accuracy not yet measured
- Premisecitation
In a retrospective cross-sectional Asian study, participants younger than 50 years had a higher risk of gallstones (OR = 5.4; 95% CI 2.3-12.7) if they were obese and had features of metabolic syndrome.
“a retrospective cross-sectional Asian study [15] observed participants younger than 50 years to have a higher risk of gallstones (OR = 5.4; 95% CI 2.3-12.7)if they were obese and showed features of the metabolic syndrome.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] source
- Premisecitation
Increased body weight is an established risk factor for gallstone formation.
“Increased body weight is an established risk factor for gallstone formation”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [8] source
- Premisecitation
The influence of body weight on gallstones has been suggested to occur independently of age.
“The influence of body weight on gallstones has also recently been suggested to occur independently of age.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] source
The Results (Baseline characteristics; page unavailable) report higher gallstone rates in certain obesity/metabolic phenotypes in both age groups, and the Discussion reports an association after adjustment for age. But the Results also find a significant interaction by age: the obesity/metabolic phenotypes were significant risk factors only below age 50. The paper therefore supports an association beyond age alone, not an influence that is the same regardless of age. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Randomized controlled trials in obese patients demonstrated that the risks of gallstones during weight loss diets are mitigated to a certain degree when the diets have a higher fat content.
“Randomized controlled trials in obese patients have demonstrated these risks to be mitigated to a certain degree when weight loss diets have a higher fat content [37,52,53].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [37] source
- cites [52] source
The Abstract and Discussion address whole-grain intake, body weight, adiposity, and dietary fat, not gallstone risk. Searches for gallstones, gallbladder risk, and higher-fat weight-loss diets found no passage in our copy reporting the claimed randomized-trial finding. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [53] source
The Introduction discusses trials of low-energy-density diets for weight loss, and the Discussion reports weight change among free-living women; neither addresses gallstones. Searches for gallstones, gallbladder risk, and higher-fat weight-loss diets found no passage reporting the claimed risk reduction in obese patients. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
In patients with gallstones, omega-3 fatty acid supplementation reduced the cholesterol saturation index in bile.
“In patients with gallstones, omega-3 fatty acid supplementation reduced the cholesterol saturation index in bile [73].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [73] source
The paper’s Discussion reports an association between recreational physical activity and lower cholecystectomy risk in women. Our copy does not address omega-3 supplementation or a change in bile cholesterol saturation; searches for those terms and for fish oil found no relevant passage. The supplied passages have no page numbers. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Reducing energy-dense foods, particularly those high in sugar, has beneficial effects on both weight and gallstone risk.
“Reducing energy-dense foods, particularly those high in sugar, has shown beneficial effects on both weight and gallstone risk [60].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [60] source
The Results (page unavailable) examine fruit and vegetable consumption and cholecystectomy risk, with BMI and energy intake treated as adjustment variables. Searches for energy-dense foods, sugar, and weight loss found no passage showing that reducing sugary foods benefits both weight and gallstone risk. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Morbidity and mortality for cholecystectomy in obese patients not undergoing bariatric surgery do not appear to be higher than those of the general population.
“Generally, the morbidity and mortality for cholecystectomy in obese patients not undergoing bariatric surgery do not appear to be higher than those of the general population [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] source
- Premisecitation
In the Swedish Obese Subjects study, the above risks were more pronounced during the first 5 years after surgery.
“The above risks were more pronounced during the first 5 years after surgery.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] source
- Premisecitation
The risks of bariatric surgery differ by type, with laparoscopic Roux-en-Y displaying a higher risk than gastric banding or sleeve resection.
“These risks do, however, differ depending on the type of bariatric surgery, with the laparoscopic Roux-en-Y surgery displaying a higher risk than either gastric banding or sleeve resection [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] source
- Premisecitation
Rapid weight loss can predispose to a lithogenic state and subsequently the formation of gallstones.
“Rapid weight loss can predispose to a lithogenic state and subsequently the formation of gallstones [27].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] source
- Premisecitation
Increased risk associated with abdominal adiposity can occur independently of BMI.
“The increased risk associated with abdominal adiposity can occur independently of BMI, as illustrated in 2 cohorts from the USA [10,11].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
A comparable incidence (30%) of gallstones after sleeve gastrectomy was reported at 6-12 months postsurgery in a prospective study.
“A comparable incidence (30%) of gallstones after sleeve gastrectomy was reported at 6-12 months postsurgery in a prospective study [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] source
- Premisecitation
Weight loss induced after bariatric surgery initiates biliary sludge and gallstones in 30% of cases during the 6-month period after gastric bypass or biliopancreatic diversion.
“weight loss induced after bariatric surgery has been reported to initiate biliary sludge (composed of precipitated lipid particles such as aggregated crystals or microliths) and gallstones in 30% of cases during the 6-month period after receiving a gastric bypass or biliopancreatic diversion [30,31].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Central adiposity is associated with gallstone formation compared to limb or lower-extremity adiposity.
“prospective cohort studies showing an association between gallstone formation and central adiposity as compared to limb or lower-extremity adiposity [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] source
- Premisecitation
Cholesterol gallstones result from accumulation of cholesterol monohydrate crystals precipitating in gallbladder bile containing excess cholesterol as compared to bile salts and phospholipids.
“The primary risk is the occurrence of cholesterol gallstones, which result from the accumulation of cholesterol monohydrate crystals precipitating in gallbladder bile containing excess cholesterol as compared to bile salts and phospholipids [18].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] source
- Premisecitation
These risks have not been reported with laparoscopic gastric banding.
“These risks, however, have not been reported with laparoscopic gastric banding [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] source
- Premisecitation
The incidence of cholecystectomy ranges from 3.3% to 14.7% in the 6-24 months after bariatric surgery.
“Other studies have shown the incidence of cholecystectomy to range from 3.3 and 14.7% in the 6-24 months after bariatric surgery [42,43].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Weight fluctuations increase the risk of requiring a cholecystectomy.
“Weight fluctuations also increase the risk of requiring a cholecystectomy [35].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] source
- Premisecitation
Legumes, olive oil, and nuts are reported to reduce the risk of cholecystectomy.
“Other foods reported to reduce the risk of cholecystectomy include legumes, olive oil [68], and nuts [69].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
In rapid weight loss, such as after bariatric surgery, prophylactic UDCA during the initial 6 months reduces the incidence of both gallstones and biliary symptoms.
“In the case of rapid weight loss, such as in the setting of bariatric surgery, prophylactic UDCA during the initial 6 months has been demonstrated to reduce the incidence of both gallstones and biliary symptoms.”
Quote in the paperSubstantial claim - Premisecitation
Reducing the time of overnight fasting to less than 12 hours might mitigate gallbladder hypomotility, as suggested by observational data.
“Additionally, gallbladder hypomotility might be mitigated by reducing the time of overnight fasting to less than 12 h, as suggested by observational data [76].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] source
- Premisecitation
After 12 months of follow-up, 4 (4.2%) vs 24 (25.2%) patients in the UDCA and control groups developed gallstones, respectively (p < 0.05).
“After 12 months of followup, 4 (4.2%)versus 24 (25.2%)patients in the UDCA and control groups developed gallstones, respectively (p < 0.05).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationnone given
Excess body weight is associated with an increased risk of cholesterol gallstones.
“Excess body weight is associated with an increased risk of cholesterol gallstones.”
Quote in the paperNot a substantial claim - Premiseown data
Multivariate analyses identified UDCA as the only significant predictor of gallstone formation (HR = 0.17; 95% CI 0.06-0.48; p < 0.001).
“Multivariate analyses identified UDCA as the only significant predictor of gallstone formation (HR = 0.17; 95% CI 0.06-0.48;p < 0.001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Many patients do not receive prophylactic UDCA during the weight reduction phase in clinical practice.
“many patients do not receive prophylactic UCDA during the weight reduction phase in clinical practice [86,87].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [86]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [87]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Sensible weight loss strategies can mitigate the increased risk of cholesterol gallstones associated with excess body weight.
“sensible weight loss strategies can mitigate this risk”
Quote in the paperSubstantial claim - Premisecitation
Consumption of high-fiber and calcium-rich foods reduces the lithogenicity of hydrophobic bile salts.
“a reduction in the Visc Med 2021;37:254-260 DOI: 10.1159/000516418 lithogenicity of hydrophobic bile salts was demonstrated with consumption of high-fiber and calcium-rich foods [66].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] source
- Interpretationcitation
Prophylactic UDCA during weight reduction reduces the incidence of gallstone formation or symptomatic gallstone occurrence.
“prophylactic ursodeoxycholic acid during the period of weight reduction has been demonstrated to reduce the incidence of gallstones formation or symptomatic gallstone occurrence.”
Quote in the paperSubstantial claim - Premisecitation
Several studies have reported physical activity as having protective effects on the formation of gallstones.
“In fact, several studies have reported physical activity as having protective effects on the formation of gallstones [34,63,[77][78][79].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34,63,[77][78][79]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
A higher dose of UDCA has not shown greater benefits in patients receiving gastric bypass.
“A higher dose has not shown greater benefits either, as illustrated in a randomized trial in patients receiving gastric bypass [31].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] source
- Premisecitation
A randomized study in pregnant women reported a lack of significant effects of physical activity on gallstones.
“A lack of significant effects on gallstones was also reported in pregnant women taking part in a randomized study [81].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] source
- Premisecitation
Omega-3 fatty acid supplementation improved gallbladder motility in patients with hypertriglyceridemia.
“The omega-3 group did, however, display improved gallbladder motility in patients with hypertriglyceridemia [75].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] source
- Premisecitation
Fiber supplementation during weight loss did not lead to significant benefits in terms of gallstone development in a randomized study with obese participants.
“However, fiber supplementation during weight loss did not lead to significant benefits in terms of gallstone development in a randomized study with obese participants [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] source
- It may state two separate claims as one. 27
- Probably not a substantial claim. 4
- The quote only partly states this claim. 1
It may state two separate claims as one.
PremisecitationUnsaturated fatty acids reduce gallstone risk, while saturated and trans fats increase it.
“Dietary lipids are mediators of gallstone risk, with unsaturated fatty acids displaying risk reduction properties and saturated and trans fats increasing the risk [70][71][72].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [70] source
The Patients and methods passage reports that fish oil improved gall-bladder motility in patients with hypertriglyceridaemia, a proposed contributor to gallstone risk. The paper does not establish that unsaturated fatty acids reduce gallstone incidence, and the passages do not address increased risk from saturated or trans fats. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [71] source
The Discussion (page unavailable) explicitly reports no association between gallstones and saturated, monounsaturated, or polyunsaturated fat intake, contrary to the claimed risk increase and reduction. The Results likewise report no association for these fats; the paper does not address trans fats. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [72] source
It may state two separate claims as one.
PremisecitationIn a mendelian randomization study of 77,679 individuals, symptomatic gallstones occurred in 5.2% (4,106 individuals) over up to 34 years of follow-up, with findings more distinct in women.
“This report showed symptomatic gallstones in 5.2% (4,106 individuals) of cases in up to 34 years of follow-up, with the findings being more distinct in women.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [8] source
Patients and Methods gives 67,314 plus 10,365 participants (77,679 total), and Table 1 reports 4,106 with symptomatic gallstone disease. The Results report follow-up ranging up to 34.4 years and a stronger BMI association in women. However, Table 1 and the Discussion give the proportion as 5.3%, not 5.2%. (LLM, conf=0.90)
Experimental — accuracy not yet measured
It may state two separate claims as one.
PremisecitationIncreased body weight is associated with reduced gallbladder motility, which contributes to stone production.
“Increased body weight is additionally associated with reduced gallbladder motility, another factor that contributes to stone production [21].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [21] source
The Discussion (page not provided) says obesity is closely related to stone formation and that increased gallbladder wall thickness may reduce motility. It links the possible motility reduction to gallbladder inflammation, however, not to increased body weight; it also presents that mechanism as uncertain. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationCholecystectomy is the gold standard treatment for symptomatic gallstones.
“for which (laparoscopic) cholecystectomy (gallbladder removal) is the gold standard treatment [1].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] source
The Gallstones section (page unavailable) says most hospitalizations involving gallstones were for cholecystectomy and that many procedures were laparoscopic. It does not identify cholecystectomy as the gold-standard treatment or specifically address symptomatic gallstones. (LLM, conf=0.83)
Experimental — accuracy not yet measured
It may state two separate claims as one.
PremisecitationBoth obesity and abdominal obesity increase the risk of stone formation and of requiring cholecystectomy because of higher likelihood of symptomatic stones.
“Both obesity and abdominal obesity increase the risk not only of stone formation but also of requiring surgical treatment (cholecystectomy) because of the higher likelihood of presenting with symptomatic stones [10,12,13].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [10] source
The Results and Conclusion (pages unavailable) associate abdominal adiposity with increased cholecystectomy risk in women, independently of BMI. The Methods say symptomatic gallstones are the main indication for surgery, but the Discussion says the study did not screen for gallstones. It therefore does not establish that obesity increases stone formation or that a greater likelihood of stones becoming symptomatic explains the surgical risk. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [12] source
- cites [13] source
It may state two separate claims as one.
PremisecitationA minimum dose of 500 mg/day of UDCA is recommended, and this dose is more effective than 300 mg/day in reducing the risk of gallstones forming during a 6-week period and after 3-4 months.
“A minimum dose of 500 mg/ day is recommended, as shown in clinical trials and a meta-analysis of such trials, with this dose being more effective than 300 mg/day in reducing the risk of gallstones forming during a 6-week period but also after 3-4 months [53].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [53] source
The Discussion addresses dietary energy density and weight gain over six years, not gallstone prevention. Searches of our untruncated copy for UDCA, the 500-versus-300 mg/day comparison, and gallstone formation at six weeks or three to four months found no relevant passage. (LLM, conf=0.78)
Experimental — accuracy not yet measured
It may state two separate claims as one.
PremisecitationThe increased risks of gallstones with bariatric surgery and very low-calorie diets are approximately 30% and 25%, respectively.
“The increased risks of gallstones have been illustrated with 2 popular weight reduction methods, i.e., bariatric surgery and very low-calorie diets [26][27][28]51], with approximate risks of 30 and 25%, respectively [26,28].”
Quote in the paperNot a substantial claim0 of 2 sources checkedIt may state two separate claims as one.
PremisecitationConcomitant cholecystectomy results in longer operation times, longer hospital stays, and higher complication rates.
“Studies have reported concomitant cholecystectomy to result in longer operation times, longer hospital stays, and higher complication rates [39,40].”
Quote in the paperSubstantial claim0 of 2 sources checkedIt may state two separate claims as one.
PremisecitationAbdominal adiposity is associated with insulin resistance, which is reported as a key factor in gallstone formation due to its stimulating effects on hepatic cholesterol secretion.
“Abdominal adiposity is associated with insulin resistance which, given its stimulating effects on hepatic cholesterol secretion, is reported as a key factor in gallstone formation [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] source
It may state two separate claims as one.
PremisecitationIn the Swedish Obese Subjects study, during 26 years of follow-up, the control group had modest weight changes (3% fluctuations), while the surgical group had weight loss averaging 25% at 2 years and 16% at both 10 and 15 years.
“During 26 years of follow-up, modest weight changes were observed in the control group (3% fluctuations), in contrast to the surgical group where weight loss averaged 25% at 2 years and 16% at both 10 and 15 years.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] source
It may state two separate claims as one.
PremisecitationIn general, weight loss reduces the risk of gallstones, except in extremely rapid weight loss (>1.5 kg/week) and excessive weight reduction (>25% body weight).
“In general, weight loss reduces the risk of gallstones, with the exception of 2 specific settings: weight loss that is extremely rapid (i.e., >1.5 kg/week) and excessive weight reduction (i.e., >25% body weight) [25][26][27].”
Quote in the paperSubstantial claim0 of 3 sources checkedIt may state two separate claims as one.
PremisecitationCholesterol supersaturation of gallbladder bile has been documented in obese patients but not in nonobese controls.
“cholesterol supersaturation of gallbladder bile has been documented in obese patients but not in nonobese controls [20].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
It may state two separate claims as one.
PremisecitationIn the Swedish Obese Subjects study, symptomatic gallstone incidence differed significantly (p < 0.001), with the surgery group reporting 307 first-time events versus 252 in controls.
“Symptomatic gallstone incidence differed significantly (p < 0.001), with the surgery group reporting 307 first-time events versus 252 in the controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] source
It may state two separate claims as one.
PremisecitationModerate (4.5-8.5 kg) and severe (≥9 kg) fluctuations in a single weight cycle increase the risk of cholecystectomy by 31% and 68%, respectively.
“Syngal et al. [35] observed both moderate (4.5-8.5 kg) and severe (≥9 kg) fluctuations in a single weight cycle to increase the risk of cholecystectomy by 31 and 68%, respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] source
It may state two separate claims as one. The quote only partly states this claim.
PremisecitationIn patients with asymptomatic gallstones treated with UDCA for 6 months after bariatric surgery, only 1 of 61 required cholecystectomy and 1 reported symptoms, while 59 remained asymptomatic.
“Della Penna et al. [49] followed up 61 patients with asymptomatic gallstones treated with ursodeoxycholic acid (UDCA) for 6 months after bariatric surgery (either laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy).”
- Also stated in: § Prevention and Treatment of Gallstones in Obesity · plain
“Cholecystectomy was required in 1 patient only who had undergone sleeve gastrectomy.”
- Also stated in: § Prevention and Treatment of Gallstones in Obesity · plain
“The remaining 59 patients remained asymptomatic with UDCA prophylaxis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] source
- Also stated in: § Prevention and Treatment of Gallstones in Obesity · plain
It may state two separate claims as one.
PremisecitationIn the Swedish Obese Subjects study, complicated gallstones and cholecystectomies were more frequent in the surgery group: 172 vs 144 first-time events (p < 0.006) and 230 vs 170 cases (p < 0.001).
“A similar trend was observed for complicated gallstones and the rate of cholecystectomies, with 172 versus 144 first-time events (p < 0.006) and 230 versus 170 cases (p < 0.001), respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] source
It may state two separate claims as one.
PremisecitationIncreased body fat is lithogenic, and higher body weight is associated with greater risk of cholesterol stones in the gallbladder.
“Thus, increased body fat is lithogenic [19], and the higher the body weight, the greater the risk of cholesterol stones in the gallbladder [12].”
Quote in the paperSubstantial claim0 of 2 sources checkedIt may state two separate claims as one.
PremisecitationAlterations of the ratio of cholesterol to bile salts within the gallbladder occur in weight fluctuations and rapid weight loss, reflecting increased hepatic cholesterol secretion and synthesis and reduced secretion of bile salts.
“Alterations of the ratio of choles-DOI: 10.1159/000516418 terol to bile salts within the gallbladder were observed in the setting of weight fluctuations and in rapid weight loss [37], reflecting increased hepatic cholesterol secretion and synthesis as well as a reduced secretion of bile salts [18].”
Quote in the paperSubstantial claim0 of 2 sources checkedIt may state two separate claims as one.
PremisecitationThe risk of secondary cholecystectomy after laparoscopic Roux-en-Y reconstruction is 6.8%, with 5.3% of these cases presenting with symptoms.
“The risk of secondary cholecystectomy was demonstrated to be 6.8% (with 5.3% of these cases presenting with symptoms) after laparoscopic Roux-en-Y reconstruction, as reported in a meta-analysis of 13 studies, 12 of which were retrospective [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
PremisecitationThe Swedish Obese Subjects study reported an overall low cumulative incidence for cholecystectomy after bariatric surgery.
“The Swedish Obese Subjects study [50] also supports the recent guidelines, reporting an overall low cumulative incidence for cholecystectomy after bariatric surgery.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] source
It may state two separate claims as one.
PremisecitationImpairment in gallbladder motility occurs in weight fluctuations and rapid weight loss, triggering the formation of biliary sludge.
“An impairment in gallbladder motility also occurs, which triggers the formation of biliary sludge [37,38].”
Quote in the paperSubstantial claim0 of 2 sources checkedIt may state two separate claims as one.
PremisecitationProphylactic ursodeoxycholic acid during the weight reduction phase reduces the formation of gallstones regardless of the method of weight loss (low-calorie diets or bariatric surgery), with reductions as high as 58% reported in randomized controlled trials.
“During the weight reduction phase, prophylactic ursodeoxycholic acid has shown great promise in reducing the formation of gallstones regardless of the method of weight loss, i.e., low-calorie diets or bariatric surgery, with reductions as high as 58% reported in randomized controlled trials [25,29,31,53,[82][83][84][85].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25,29,31,53,[82][83][84][85]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper may give no reason why it holds.
Premisenone givenRecent guidelines do not recommend simultaneous cholecystectomy during bariatric surgery unless the patient has a preexisting diagnosis of symptomatic gallstones.
“recent guidelines do not recommend simultaneous cholecystectomy during surgery unless the patient has a preexisting diagnosis of symptomatic gallstones”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationIn obese women without gallstones randomized to omega-3 fatty acids, UDCA, or placebo for 6 weeks, no reduction of biliary cholesterol saturation was observed, and none developed gallstones during the intervention.
“Another study in obese women without gallstones who were randomized to receiving omega-3 fatty acids or UDCA or placebo for 6 weeks did not observe a reduction of biliary cholesterol saturation, despite the fact that none of the participants developed gallstones during this intervention period [74].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] source
It may state two separate claims as one.
Interpretationnone givenRapid weight loss or weight cycling might trigger a lithogenic cascade and further increase the probability of either gallstones forming or of stones becoming symptomatic.
“rapid weight loss or weight cycling might trigger a lithogenic cascade and further increase the probability of either gallstones forming or of stones becoming symptomatic”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationIn a randomized study, moderate training improved gallbladder motility, but results were similar in the control group.
“improvements in gallbladder motility were observed in a randomized study, where the intervention included moderate training, but the results were similar in the control group [80].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] source
It may state two separate claims as one.
InterpretationreasoningHealthy weight loss diets combined with regular physical activity can promote successful weight loss and weight maintenance and reduce the risk of gallstones.
“Healthy weight loss diets combined with regular physical activity can promote successful weight loss and weight maintenance and reduce the risk of gallstones.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationStudies suggest the first 6 months after surgery are the most critical because they are associated with the greatest reduction in body weight, with UDCA showing mild benefits after the first 6 months that do not justify prolonged prophylaxis.
“Studies suggest the first 6 months after surgery to be the most critical because they are associated with the greatest reduction in body weight, with UDCA showing mild benefits after the first 6 months that do not justify prolonged prophylaxis [88].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper may give no reason why it holds.
Interpretationnone givenHealthy nutrition emphasizing plant foods and unsaturated fats combined with regular physical activity can promote successful weight loss and weight maintenance.
“Healthy nutrition with an emphasis on plant foods and unsaturated fats combined with regular physical activity can promote successful weight loss and weight maintenance.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premiseown dataThe majority of gallstones in that study were asymptomatic, with only 28.6% of participants displaying symptoms.
“The majority were asymptomatic, with only 28.6% of participants displaying symptoms.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationIn a randomized study of 190 patients undergoing 1 anastomosis gastric bypass, the incidence of gallstones after 3 months was 0 vs 4 (4.2%) in the UDCA and control groups, and 3 (3.1%) vs 21 (22.1%) at 6 months.
“The incidence of gallstones after 3 months was 0 versus 4 (4.2%) in the UDCA and control groups, respectively, and 3 (3.1%)versus 21 (22.1%) at 6 months.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
Each extra kilogram of body fat yields the production of approximately 20 mg of additional cholesterol.
“It has been estimated that each extra kilogram of body fat yields the production of approximately 20 mg of additional cholesterol.”
The paper relies on this without support.
Excess cholesterol is secreted by hepatocytes as a direct result of increased body weight.
“This excess cholesterol is secreted by hepatocytes as a direct result of increased body weight.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Three cases among 95 are reported as 3.1%
MinorThree of 95 patients is 3.158%, which rounds to 3.2% at the reported precision.
Reported 3.1 · recomputed 3.157895
“These patients were randomized to either 600 mg/day of oral UDCA (n = 95) or to a control group (n = 95) for 6 months.The incidence of gallstones after 3 months was 0 versus 4 (4.2%) in the UDCA and control groups, respectively, and 3 (3.1%)versus 21 (22.1%) at 6 months.”
Symptomatic gallstone percentage does not match the reported count
MinorOf 77,679 individuals, 4,106 is 5.286%, which rounds to 5.3%, not 5.2%.
Reported 5.2 · recomputed 5.285856
“a mendelian randomization study in 77,679 individuals [8].This report showed symptomatic gallstones in 5.2% (4,106 individuals)”
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Intake of sugar-sweetened beverages and weight gain: a systematic review
Malik, V. S., Schulze, M. B., & Hu, F. B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.274 · Cited by 2,100
Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis
Vartanian, L. R., Schwartz, M. B., & Brownell, K. D. (2007) · American Journal of Public Health · doi:10.2105/ajph.2005.083782 · Cited by 1,863
Lammert, F., Gurusamy, K., Ko, C. W., Miquel, J.-F., Méndez-Sánchez, N., Portincasa, P., van Erpecum, K. J., van Laarhoven, C. J., & Wang, D. Q.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.24 · Cited by 822
Self-citationBurden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 710
Portincasa, P., Moschetta, A., & Palasciano, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69044-2 · Cited by 643
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.005 · Cited by 576
Kwaifa, I. K., Bahari, H., Yong, Y. K., & Noor, S. M. (2020) · Biomolecules · doi:10.3390/biom10020291 · Cited by 345
Sugerman, H. J., Brewer, W. H., Shiffman, M. L., Brolin, R. E., Fobi, M. A. L., Linner, J. H., MacDonald, K. G., MacGregor, A. M., Martin, L. F., Oram-Smith, J. C., et al. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80115-9 · Cited by 336
Weight, Diet, and the Risk of Symptomatic Gallstones in Middle-Aged Women
Maclure, K. M., Hayes, K. C., Colditz, G. A., Stampfer, M. J., Speizer, F. E., & Willett, W. C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210902 · Cited by 297
Hooper, L., Abdelhamid, A. S., Moore, H. J., Douthwaite, W., Skeaff, C. M., & Summerbell, C. (2012) · BMJ · doi:10.1136/bmj.e7666 · Cited by 285
Genetic and environmental influences on symptomatic gallstone disease
Katsika, D., Grjibovski, A. M., Einarsson, C., Lammert, F., Lichtenstein, P., & Marschall, H. (2005) · Hepatology · doi:10.1002/hep.20654 · Cited by 277
Self-citationThe natural history of gallstones: The GREPCO experience
Attili, A. F., Santis, A. D., Capri, R., Repice, A. M., & Maselli, S. (1995) · Hepatology · doi:10.1002/hep.1840210309 · Cited by 269
Broomfield, P. H., Chopra, R., Sheinbaum, R. C., Bonorris, G. G., Silverman, A., Schoenfield, L. J., & Marks, J. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192403 · Cited by 222
Miller, K., Hell, E., Lang, B., & Lengauer, E. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000094305.77843.cf · Cited by 200
The natural history of gallstones: the GREPCO experience
The GREPCO Group, Attili, A. F., Capri, R., Repice, A. M., & Maselli, S. (1991) · Springer eBooks · doi:10.1007/978-94-011-3744-7_7 · Cited by 190
Independent Risk Factors for Gallstone Formation in a Region with High Cholelithiasis Prevalence
Völzke, H., Baumeister, S. E., Alte, D., Hoffmann, W., Schwahn, C., Simon, P., John, U., & Lerch, M. M. (2005) · Digestion · doi:10.1159/000084525 · Cited by 187
Mechanisms of Disease: the genetic epidemiology of gallbladder stones
Lammert, F., & Sauerbruch, T. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0257 · Cited by 182
Self-citationLi, V. K. M., Pulido, N., Fajnwaks, P., Szomstein, S., & Rosenthal, R. (2009) · Surgical Endoscopy · doi:10.1007/s00464-008-0204-6 · Cited by 181
Gallstone Formation During Weight-Reduction Dieting
Liddle, R. A. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390080036009 · Cited by 174
Diet, physical activity, and gallstones—a population-based, case-control study in southern Italy
Misciagna, G., Centonze, S., Leoci, C., Guerra, V., Cisternino, A. M., Ceo, R., & Trevisan, M. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.120 · Cited by 173
Prospective study of dietary energy density and weight gain in women
Bes‐Rastrollo, M., van Dam, R. M., Martínez‐González, M. Á., Li, T. Y., Sampson, L., & Hu, F. B. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.769 · Cited by 159
Recreational Physical Activity and the Risk of Cholecystectomy in Women
Leitzmann, M. F., Rimm, E. B., Willett, W. C., Spiegelman, D., Grodstein, F., Stampfer, M. J., Colditz, G. A., & Giovannucci, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411101 · Cited by 157
Wudel, L. J., Wright, J. K., Debelak, J. P., Allos, T. M., Shyr, Y., & Chapman, W. C. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2001.6322 · Cited by 154
Stender, S., Nordestgaard, B. G., & Tybjaerg-Hansen, A. (2013) · Hepatology · doi:10.1002/hep.26563 · Cited by 153
Weinsier, R. L., Wilson, L. J., & Lee, J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80394-5 · Cited by 148
Is Routine Cholecystectomy Required During Laparoscopic Gastric Bypass?
Villegas, L., Schneider, B., Provost, D. A., Chang, C. G., Scott, D. J., Sims, T. L., Hill, L., Hynan, L. S., & Jones, D. B. (2004) · Obesity Surgery · doi:10.1381/096089204772787301 · Cited by 147
Prospective study of abdominal adiposity and gallstone disease in US men
Tsai, C.-J., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.38 · Cited by 145
The Relation of Physical Activity to Risk for Symptomatic Gallstone Disease in Men
Leitzmann, M. F., Giovannucci, E. L., Rimm, E. B., Stampfer, M. J., Spiegelman, D., Wing, A. L., & Willett, W. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00001 · Cited by 140
Warschkow, R., Tarantino, I., Ukegjini, K., Beutner, U., Güller, U., Schmied, B. M., Müller, S. A., Schultes, B., & Thurnheer, M. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0852-4 · Cited by 135
Is Routine Cholecystectomy Required During Laparoscopic Gastric Bypass?
Villegas, L., Schneider, B., Provost, D. A., Chang, C. G., Scott, D., Sims, T. L., Hill, L., Hynan, L. S., & Jones, D. B. (2004) · Obesity Surgery · doi:10.1381/096089204322857573 · Cited by 133
Gutt, C. N., Jenssen, C., Barreiros, A. P., Götze, T. O., Stokes, C. S., Jansen, P. L., Neubrand, M., Lammert, F., der Konsensuskonferenz, F. D. T., (DGIM), D. G. F. I. M. E. V., et al. (2018) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0644-2972 · Cited by 130
Self-citationChanges in gallbladder bile composition following gallstone formation and weight reduction
Shiffman, M. L., Sugerman, H. J., Kellum, J. M., & Moore, E. W. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91115-k · Cited by 125
Stokes, C. S., Gluud, L. L., Casper, M., & Lammert, F. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.031 · Cited by 118
Self-citationElective Cholecystectomy During Laparoscopic Roux-En-Y Gastric Bypass: Is it Worth the Wait?
Hamad, G. G., Ikramuddin, S., Gourash, W. F., & Schauer, P. R. (2003) · Obesity Surgery · doi:10.1381/096089203321136638 · Cited by 115
The Role of Gallbladder Emptying in Gallstone Formation During Diet–Induced Rapid Weight Loss
Gebhard, R. L., Prigge, W. F., Ansel, H. J., Schlasner, L., Ketover, S. R., Sande, D., Holtmeier, K., & Peterson, F. J. (1996) · Hepatology · doi:10.1002/hep.510240313 · Cited by 113
Shiffman, M. L., Kaplan, G. D., Brinkman-Kaplan, V., & Vickers*, F. F. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00002 · Cited by 113
Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany
Schafmayer, C., Hartleb, J., Tepel, J., Albers, S., Freitag, S., Völzke, H., Buch, S., Seeger, M., Timm, B., Kremer, B., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-36 · Cited by 111
Therapy of gallstone disease: What it was, what it is, what it will be
Portincasa, P. (2012) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v3.i2.7 · Cited by 107
Worni, M., Guller, U., Shah, A., Gandhi, M., Shah, J., Rajgor, D., Pietrobon, R., Jacobs, D. O., & Østbye, T. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0575-y · Cited by 104
Whole-grain intake as a marker of healthy body weight and adiposity
Harland, J. I., & Garton, L. E. (2008) · Public Health Nutrition · doi:10.1017/s1368980007001279 · Cited by 104
How frequently and when do patients undergo cholecystectomy after bariatric surgery?
Tsirline, V. B., Keilani, Z. M., El Djouzi, S., Phillips, R. C., Kuwada, T. S., Gersin, K., Simms, C., & Stefanidis, D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.10.011 · Cited by 98
Festi, D., Colecchia, A., Orsini, M., Sangermano, A., Sottili, S., Simoni, P., Mazzella, G., Villanova, N., Bazzoli, F., Lapenna, D., et al. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800634 · Cited by 90
Dietary energy density predicts women's weight change over 6 y
Savage, J. S., Marini, M., & Birch, L. L. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.677 · Cited by 88
Tsai, C., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.016 · Cited by 86
Worobetz, L., Inglis, F. G., & Shaffer, E. A. (1993) · PubMed · Cited by 85
Insulin Resistance Causes Human Gallbladder Dysmotility
Nakeeb, A., Comuzzie, A. G., Al-Azzawi, H., Sonnenberg, G. E., Kissebah, A. H., & Pitt, H. A. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.04.005 · Cited by 84
Central adiposity, regional fat distribution, and the risk of cholecystectomy in women
Tsai, C.-J., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2006) · Gut · doi:10.1136/gut.2005.076133 · Cited by 83
Long-Term Weight Patterns and Risk for Cholecystectomy in Women
Syngal, S., Coakley, E. H., Willett, W. C., Byers, T., Williamson, D. F., & Colditz, G. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00003 · Cited by 79
Tsai, C.-J., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-7-200410050-00007 · Cited by 77
Swartz, D. E., & Felix, E. L. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.08.002 · Cited by 75
Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men
Tsai, C.-J., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2005) · Gut · doi:10.1136/gut.2003.031435 · Cited by 73
Adams, L. B., Chang, C., Pope, J., Kim, Y., Liu, P., & Yates, A. (2016) · Obesity Surgery · doi:10.1007/s11695-015-1858-5 · Cited by 71
O'brien, P. E. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.8.908 · Cited by 71
Fruit and Vegetable Consumption and Risk of Cholecystectomy in Women
Tsai, C., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.040 · Cited by 69
Diet and gallstones in italy: The cross-sectional MICOL results†
Attili, A. F., Scafato, E., Marchioli, R., Marfisi, R. M., & Festi, D. (1998) · Hepatology · doi:10.1002/hep.510270605 · Cited by 63
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P., Loria, C. M., & Smith, S. C. J. (2010) · Obesity and metabolism · doi:10.14341/2071-8713-5281 · Cited by 62
Differences in diet and food habits between patients with gallstones and controls.
Ortega, R. M., Fernández-Azuela, M., Encinas-Sotillos, A., Andrés, P., & López-Sobaler, A. M. (1997) · Journal of the American College of Nutrition · doi:10.1080/07315724.1997.10718655 · Cited by 61
Laparoscopic cholecystectomy in morbidly obese patients
Ammori, B. J., Vezakis, A., Davides, D., Martin, I. G., Larvin, M., & McMahon, M. J. (2001) · Surgical Endoscopy · doi:10.1007/s004640000019 · Cited by 61
Coupaye, M., Calabrese, D., Sami, O., Msika, S., & Ledoux, S. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.11.022 · Cited by 58
Gallbladder and gastric motility in obese newborns, pre‐adolescents and adults
Di Ciaula, A., Wang, D. Q., & Portincasa, P. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07149.x · Cited by 54
Jonkers, I. J. A. M., Smelt, A. H. M., Ledeboer, M., Hollum, M. E., Biemond, I., Kuipers, F., Stellaard, F., Boverhof, R., Meinders, A. E., Lamers, C. H. B. W., et al. (2003) · Gut · doi:10.1136/gut.52.1.109 · Cited by 54
Dietary N–3 Polyunsaturated Fatty Acids Decrease Biliary Cholesterol Saturation in Gallstone Disease
Berr, F., Holl, J., Jüngst, D., Fischer, S., Richter, W. O., Seifferth, B., & Paumgartner, G. (1992) · Hepatology · doi:10.1002/hep.1840160418 · Cited by 53
Weight Cycling and Risk of Gallstone Disease in Men
Tsai, C.-J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.21.2369 · Cited by 53
Long-Term Intake of Dietary Fiber and Decreased Risk of Cholecystectomy in Women
Tsai, C.-J., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30153.x · Cited by 52
Napolitano, P. G., Lee, S., Schulte, S. J., Ciol, M. A., Beresford, S. A. A., & Ko, C. W. (2013) · American Journal of Perinatology · doi:10.1055/s-0033-1334455 · Cited by 51
Sahi, T., Paffenbarger, R. S., Hsieh, C.-C., & Lee, I.-M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009505 · Cited by 50
CENTRAL ADIPOSITY AND GALLBLADDER DISEASE IN MEXICAN AMERICANS
HAFFNER, S. M., DIEHL, A. K., STERN, M. P., & HAZUDA, H. P. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115171 · Cited by 50
Frequent nut consumption and decreased risk of cholecystectomy in women
Tsai, C.-J., Leitzmann, M. F., Hu, F. B., Willett, W. C., & Giovannucci, E. L. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.76 · Cited by 49
Su, P.-Y., Hsu, Y.-C., Cheng, Y.-F., Kor, C.-T., & Su, W.-W. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1032-y · Cited by 49
Pizza, F., D’Antonio, D., Lucido, F. S., Tolone, S., GENIO, G. D., Dell’Isola, C., Docimo, L., & Gambardella, C. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04801-z · Cited by 49
Cholelithiasis in patients treated with a very-low-calorie diet
Kamrath, R., Plummer, L., Sadur, C., Adler, M., Strader, W., Young, R., & Weinstein, R. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.1.255s · Cited by 47
Analysis of gallbladder bile in morbid obesity
Freeman, J. B., Meyer, P. D., Printen, K. J., Mason, E. E., & DenBesten, L. (1975) · The American Journal of Surgery · doi:10.1016/0002-9610(75)90292-5 · Cited by 46
Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass
Kim, J.-J., & Schirmer, B. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.06.001 · Cited by 45
Long-term Intake of trans-Fatty Acids and Risk of Gallstone Disease in Men
Tsai, C.-J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.1011 · Cited by 45
Liu, T., Siyin, S. T., Yao, N., Duan, N., Xu, G., Li, W., Qu, J., & Liu, S. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035880 · Cited by 45
Long-Chain Saturated Fatty Acids Consumption and Risk of Gallstone Disease Among Men
Tsai, C.-J., Leitzmann, M. F., Willett, W. C., & Giovannucci, E. L. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815792c2 · Cited by 42
Williams, C. N., Gowan, R., & Perey, B. J. (1993) · Obesity Surgery · doi:10.1381/096089293765559278 · Cited by 41
Méndez-Sánchez, N., González, V., Aguayo, P., Sánchez, J. M., Tanimoto, M. A., Elizondo, J., & Uribe, M. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.9.2300 · Cited by 41
Long-term incidence of gallstone disease after bariatric surgery
Anveden, Å., Peltonen, M., Näslund, I., Torgerson, J., & Carlsson, L. M. S. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.05.025 · Cited by 39
Endothelial dysfunction in metabolic syndrome.
Cozma, A., Orasan, O. H., Sâmpelean, D., Fodor, A., Vlad, C., Negrean, V., Rednic, N. V., & Zdrenghea, D. T. (2009) · PubMed · Cited by 35
Penna, A. D., Lange, J., Hilbert, J., Archid, R., Königsrainer, A., & Quante, M. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03651-0 · Cited by 35
Routine cholecystectomy is not mandatory during morbid obesity surgery
Ellner, S. J., Myers, T. T., Piorkowski, J. R., Mavanur, A. A., & Barba, C. A. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.11.008 · Cited by 34
Physical activity and decreased risk of clinical gallstone disease among post-menopausal women
Storti, K. L., Brach, J. S., FitzGerald, S. J., Zmuda, J. M., Cauley, J. A., & Kriska, A. M. (2005) · Preventive Medicine · doi:10.1016/j.ypmed.2005.04.002 · Cited by 31
Effects of exercise training on gallbladder function in an obese female population
UTTER, A. C., WHITCOMB, D. C., NIEMAN, D. C., BUTTERWORTH, D. E., & VERMILLION, S. S. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200001000-00007 · Cited by 24
Diet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort
Barré, A., Gusto, G., Cadeau, C., Carbonnel, F., & Boutron-Ruault, M.-C. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.216 · Cited by 23
Obesity and unanticipated hospital admission following outpatient laparoscopic cholecystectomy
Reeves, J. J., Burton, B. N., Broderick, R. C., Waterman, R. S., & Gabriel, R. A. (2021) · Surgical Endoscopy · doi:10.1007/s00464-020-07514-7 · Cited by 18
Nordenvall, C., Oskarsson, V., & Wolk, A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1298-6 · Cited by 16
Ref: Gallstone formation in obese subjects undergoing a weight reduction diet
Morán, S., Milke, P., Rodríguez-Leal, G., & Uribe, M. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800588 · Cited by 6
(1993) · PubMed
The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss
Gebhard, R. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008781321
Katsika, D., Grjibovski, A., Lammert, F., Einarsson, C., Lichtenstein, P., & Marschall, H. (2004) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2004-831828
Self-citationLong-term weight patterns and risk for cholecystectomy in women
Syngal, S., Coakley, E. H., Willett, W. C., Byers, T., Williamson, D. F., & Colditz, G. A. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199905000-00024
Weight Cycling and Risk of Gallstone Disease in Men: 174
Tsai, C.-J., Leitzmann, M., Willett, W., & Giovannucci, E. (2006) · American Journal of Gastroenterology · doi:10.14309/00000434-200609001-00174
P44: Safety and efficacy of simultaneous cholecystectomy at the time of Roux-en-Y gastric bypass
Kim, J.-J., & Schirmer, B. D. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.03.105
Flagged first, then by citations
Cited by
Sorted by citations
Semaglutide for the treatment of overweight and obesity: A review
Bergmann, N. C., Davies, M. J., Lingvay, I., & Knop, F. K. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14863 · Cited by 265
Janež, A., Muzurović, E. M., Bogdański, P., Czupryniak, L., Fábryová, Ľ., Fras, Z., Guja, C., Haluzı́k, M., Kempler, P., Lalic, N. M., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01615-5 · Cited by 56
Barrea, L., Annunziata, G., Verde, L., Galasso, M., Savastano, S., Colao, A. A. L., & Muscogiuri, G. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00667-3 · Cited by 20
Sarzani, R., Landolfo, M., Pentima, C. D., Ortensi, B., Falcioni, P., Sabbatini, L., Massacesi, A., Rampino, I., Spannella, F., & Giulietti, F. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1365183 · Cited by 18
The role of bacteria in gallstone formation
Wang, D., Ye, A., & Jiang, N. (2024) · Folia Microbiologica · doi:10.1007/s12223-024-01131-w · Cited by 16
Kucheryavyy, Y. A., & Cheremushkin, S. V. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.12.201429 · Cited by 14
Ying, J., Dai, S., Fu, R., Hong, J., Dai, C., & Jin, Q. (2022) · Obesity · doi:10.1002/oby.23427 · Cited by 14
Long-term weight patterns and physical activity in gallstones
Kim, H. J., Kang, T., Kim, M. J., Swan, H., & Park, S. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-77218-8 · Cited by 13
Moiz, A., Peters, T. M., Tsoukas, M. A., Yu, O. H. Y., Filion, K. B., & Eisenberg, M. J. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103991 · Cited by 11
Between guidelines and reality; the complex decision-making of acute cholecystitis in pregnancy
Hassanesfahani, M., Villavarajan, B., Otusile, I., Williams, B. S., Tian, J., Miele, A. S., Louis, M. A., & Mandava, N. R. (2025) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-025-03768-8 · Cited by 10
Al-huniti, M., Alsardi, Y., Odeh, A., Bdour, B., Hassanat, R., Aloun, A., Sha’ban, B. W., & Nseirat, S. M. (2023) · Cureus · doi:10.7759/cureus.50649 · Cited by 10
Ruggiero, R., Longo, M., Mascolo, A., Nuzzo, M. D., Laino, L. V., Caruso, P., D'Amato, R., Rafaniello, C., Maiorino, M. I., Esposito, K., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178004 · Cited by 9
Cholelithiasis – a particular threat to women. A review of risk factors
Lazarchuk, I., Barzak, B., Woźniak, S., Mielczarek, A., & Lazarchuk, V. (2023) · Medical Journal of Cell Biology · doi:10.2478/acb-2023-0003 · Cited by 9
Practical application of semaglutide: From evidence-based research to expert decisions
Салухов, В. В., Galstyan, G. R., Khalimov, Y. S., Бакулин, И. Г., Cherkashin, D. V., Shadrichev, F. E., & Sukhotskaia, N. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-185 · Cited by 8
Gastrointestinal Symptoms in Obesity Therapy: Mechanisms, Epidemiology, and Management Strategies
Witaszek, T., Biesiada, A. M., Iskra-Trifunović, J., Babicki, M., Mastalerz–Migas, A., & Kłoda, K. (2025) · Biomedicines · doi:10.3390/biomedicines13102362 · Cited by 7
Bao, C.-Y., Ding, X.-K., Qi, Q.-F., Ye, P., & Fang, Z.-J. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i2.99826 · Cited by 6
Miyah, Y., Benjelloun, M. C., Omari, H. E., El-Mouhdi, K., & Feniche, M. E. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100839 · Cited by 6
Shi, T., Li, D., Li, D., Xie, P., Sun, J., Wang, T., Li, R., Zou, Z., Li, Z., & Ren, X. (2025) · Environmental Geochemistry and Health · doi:10.1007/s10653-024-02354-z · Cited by 6
Ataş, A. E., & Ünüvar, Ş. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1724416 · Cited by 4
Study of risk factors and liver function markers in gallstone patients in Iraqi Kurdish Women
Raheem, S., & Kakey, I. S. (2023) · passer · doi:10.24271/psr.2023.389137.1278 · Cited by 4
Hasan, R., Allahbakhsi, F., Shlyk, A. D., & Allahbakhshi, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314661 · Cited by 4
Gallbladder - Anatomy, Pathogenesis, and Treatment
Elgeidie, A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1000409 · Cited by 3
del Pozo, R. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002044 · Cited by 3
Physical Activity and Gallstone Disease
Григорьева, И. Н., Нотова, Т. Е., & Романова, Т. И. (2023) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2023-33-1-7-14 · Cited by 3
Ciaula, A. D., Khalil, M., Garruti, G., & Portincasa, P. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101056 · Cited by 2
Reduction of the risk of biliary lithiasis caused by various weight reduction options in obesity
Plotnikova, E. Y., & SUKHIKH, A. S. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-385 · Cited by 2
Prevalence of gallstones among gastric sleeve patients in Saudi Arabia
Suliman, O., Alsaedi, E. A. H., Albalawi, H. Z. H., Alshanqiti, Z., Alrehaili, M. A., Aloufi, H., Alsubhi, R. M., & Aljayyar, M. W. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20250045 · Cited by 2
Modern pharmacotherapy for cholestasis syndrome
Skvortsov, V. V., Еременко, А. А., & Васильевна, В. М. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-106 · Cited by 2
Yu, W., Xia, J., Chen, F., Jiao, P., Cui, P., Zhang, C., Wang, Y., Shan, X., & Wang, X. (2024) · 四川大学学报:医学版 · doi:10.12182/20240560501 · Cited by 2
Medical nutrition after cholecystectomy
Morozov, S. V. (2024) · Voprosy Pitaniya · doi:10.33029/0042-8833-2024-93-2-73-82 · Cited by 1
A Narrative Review of the Metabolic Benefits of GLP-1 and GIP Receptor Agonists in Obesity
Lee, A.-H., & Holmes-Walker, D. J. (2026) · Healthcare · doi:10.3390/healthcare14060734 · Cited by 1
Ali, M., Alhazmi, A., Mohieldin, A., Ahmed, W. A. M., Khedr, M. A., Osman, O. B., Hawash, M. M., Alshameri, F. A., Elfaki, N., & Alharbi, G. A. (2026) · PeerJ · doi:10.7717/peerj.21172 · Cited by 1
Pathology of the Biliary Tract: from ICD X to ICD XI
Livzan, M. A., Gaus, O. V., & Lisovskiy, M. А. (2024) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2024-20-2-98-107 · Cited by 1
The association between dietary fatty acid intake and gallstone disease: a case-control study
Sadeghi, A., Raissi-Dehkordi, N., Ghorbani, M., Rastegar, R., Zali, M., Raissi-Dehkordi, N., Yari, Z., & Hekmatdoost, A. (2025) · Nutrition & Food Science · doi:10.1108/nfs-06-2024-0196 · Cited by 1
Role of risk factors in the development of cholelithiasis
Morozov, A. M., Buinova, M., & Titova, A. (2025) · Meditsinskaya sestra · doi:10.29296/25879979-2025-04-10 · Cited by 1
Excess Body Weight and Gastrointestinal Disease
Germer, C., & Scherübl, H. (2021) · Visceral Medicine · doi:10.1159/000517251 · Cited by 1
A systematic study on 33 gallbladder stones resembling adult Clonorchis sinensis worms
Ma, R.-H., Wang, X.-F., Li, Q., Cai, H.-Y., & Luo, X.-B. (2022) · Journal of Helminthology · doi:10.1017/s0022149x22000773
Cutliffe, A. L., Vázquez, A. R., McKenna, S. L., Drummond, F. J., & Mackrill, J. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3292747/v1
Influence of dietary components on the risk of gallstone formation
Sawczuk, M., Ptak, J., Miśkiewicz, M., Marcinkowska, J., Perłowski, J., Teska, V., Koczkodon, K., Noga, R., Krompiewski, M., & Herc, A. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.65.014
Wei, S., Yu, S., Xu, Z., Qian, C., & Jia, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5320384/v1
Grundy, K., & Nelson, A. (2024) · InnovAiT Education and inspiration for general practice · doi:10.1177/17557380241292803
Watson, A., & Bitterman, J. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-72862-4_2
Association of Body Mass Index and Cholecystitis: A Retrospective Observational Study
Mehmood, Y. (2025) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2025/78422.20882
Hou, Y., Haomeng, M., Rui, L., Zhen, X., Wenhao, C., Yong, M., & Jianli, H. (2025) · Research Square · doi:10.21203/rs.3.rs-7132076/v1
Lei, S., Fu, Y., Zhang, B., Yang, H., Hu, Y., & Ji, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1676636
Qiu, X., Ye, L., & Wang, J. (2025) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2025.08.373
Chen, F., Zhang, Y., & Chen, L. (2025) · Archives of Medical Science · doi:10.5114/aoms/214619
Vpliv prehrane na nastanek žolčnih kamnov
Kravanja, K. (2024) · Repository of the University of Primorsk (University of Primorska)
Ming, Y., He, Y., Deng, J., Xu, F. F., Chen, H., Zhu, Y., Jiang, J., Liu, Y., & Leng, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1804048
Pestka, J., Figiel, A., Zaborek, P., Bernad, M., Widomska, K., & Marguła, R. (2026) · Quality in Sport · doi:10.12775/qs.2026.54.70610
Gu, L., Cai, J., Wang, F., Gao, X., Huang, Y., Zhou, Z., & Zheng, Y. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04919-x
Practical Considerations for the Use of Oral Glucagon-like Peptide-1 Receptor Agonist in India
Ashraf, H., Bakshi, S., Ekatpure, H., Kumar, N. S. P., Acharyya, M., Reddy, J. N., Ghosh, J., Goel, A., Chaudhary, R., Saini, A., et al. (2026) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_25_26
Wei, S., Yu, S., & Lan, Y. (2026) · Journal of International Medical Research · doi:10.1177/03000605261457792
Ni, W., Deng, C., & Chen, Y. (2026) · Medicine · doi:10.1097/md.0000000000049813
He, W., Yi-di, S., Wang, X., He, S.-Y., Tao, X., Yuan, S.-X., Zhou, L., & Long, E.-W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1889594
Increased risk of gallstones with obesity and rapid weight loss
Khalil, M., Ciaula, A. D., Baffy, G., Krawczyk, M. J., & Portincasa, P. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102142
Genomic and exposomic risk factors for gallstone disease
Palacios, M. M. (2026) · UCrea (University of Cantabria)
Dr. Balakrishna, G., Koushik, P., & Sirasu, M. (2026) · Student s Journal of Health Research Africa · doi:10.51168/ff03y238
Metadata
- Authors
- Stokes, C. S., & Lammert, F.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Medizinische Hochschule Hannover (DE)
- Venue
- Visceral Medicine
- Publisher
- S. Karger AG
- Published
- 2021
- Volume
- 37
- Issue
- 4
- Pages
- 254-260
- ISSN
- 2297-4725 (ISSN-L)
- 2297-475X
- PMC
- PMC8406364
- OpenAlex
- W3166882002
- Semantic Scholar
- a8dad5021dd8b7c0c125a4d2a91bcfe2e376f14f
- Cited by
- 58
- References
- 89
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 14 · 2023: 7 · 2022: 4 · 2021: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Visceral Medicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
- Health Sciences › Medicine › Gastroenterology › Biliary and Gastrointestinal Fistulas
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- gallstone disease, overweight, obesity, symptomatic gallstones, cholecystectomy, rapid weight loss, bariatric surgery, ursodeoxycholic acid, weight loss diet, physical activity, gallstone prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review